Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve repair and cardiac revascularization. The approval enables minimally invasive ...

We recently compiled a list of the 20 Most Profitable Stocks of the Last 20 Years. Intuitive Surgical, Inc. is one of the ...

Intuitive Surgical’s fourth quarter saw results above Wall Street’s expectations, driven by increased global procedure ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

If you are wondering whether Intuitive Surgical at around US$525 a share still makes sense for your portfolio, the key ...

Intuitive Surgical (NASDAQ: ISRG) reports in-line Q4 results, sets measured guidance for 2026, with an 18% revenue growth and ...

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly. The flywheel of Intuitive Surgical's ...